Advocacy & Policy

The Association of American Medical Colleges (AAMC or Association) welcomes this opportunity to comment on the Centers for Medicare and Medicaid Services’ (CMS’

The AAMC May 21 submitted a comment letter in response to HRSA’s notice to further delay the 340B Drug Pricing Program’s rule addressing drug manufacturers ceil

The Association of American Medical Colleges (AAMC) welcomes this opportunity to comment on the proposed rule entitled “Methods for Assuring Access to Covered M

AAMC President and CEO Darrell G. Kirch, MD, sent a letter to Members of Congress in support of the Opioid Workforce Act of 2018.

Organizations representing hospitals and health systems from across the country sent a letter to the House Energy and Commerce Committee expressing support for

The AAMC sent a May 14 letter to Senators Cassidy, Bennet, Grassley, Carper, Young and McCaskill outlining key recommendations in the Senate’s price transparenc

The AAMC April 26 submitted outside witness testimony to the House Appropriations Subcommittee on Labor, Health and Human Services, and Education, and Related A

The AAMC welcomes this opportunity to comment on the proposed rule entitled “Short-Term, Limited-Duration Insurance,” 83 Fed. Reg. 7437 (February 21, 2018), iss

The AAMC signed a community letter to CMS Administrator Seema Verma requesting CMS shorten the quality reporting period to a minimum of 90 days.

Community letter signed by 37 higher education organizations, and coordinated by the American Council on Education, supporting the Department of Homeland Securi